Biotech RadarJobs updated

COMPANY

Detroit R & D, Inc.

HQ: Detroit, MI source · detroitrandd.com ↗ · Midwest

Service / Tools company

DETROIT R & D, INC. has received NIH funding, most recently in fiscal 2019 for the project “SBIR PHASE II: SITE-SPECIFIC ANTIBODIES FOR GLCNACYLATED PROTEINS IN CANCER”. From public records Source · Oct 12, 2026

Keywords: ANTIBODIES ; CANCER

Profile checked Oct 10, 2026

25NIH grants

NIH awards 25

Annual award amounts. Total $6.7M.

Feedback